Company Analysis - The Dow Chemical Company


June 1, 2011
30 Pages - SKU: CICQ6480223
License type:
Debiotech S.A. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Debiotech S.A. (Debiotech) is a medical device company. The company develops therapeutic devices and diagnostic products. It operates through its product categories such as Electronic Infusion Systems, Drug Delivery Devices, Microsystems and Diagnostics. Debiotech’s drug  |  read more...
$750.00
Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Delcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic  |  read more...
$750.00
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013” provides data on the Dong-A Pharmaceutical Co., Ltd.’s research and development  |  read more...
$1,500.00
Diamyd Medical AB – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Diamyd Medical AB – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Diamyd Medical AB - Product Pipeline Review - 2013” provides data on the Diamyd Medical AB’s research and development focus. The report  |  read more...
$1,500.00
Shenhua Group Corporation Limited Petrochemicals Capacity and Company Snapshot - 2013 Update
4/30/2013 | published by: GlobalData
Shenhua Group Corporation Limited Petrochemicals Capacity and Company Snapshot - 2013 Update Summary GlobalData’s report, “Shenhua Group Corporation Limited Petrochemicals Capacity and Company Snapshot - 2013 Update” provides detailed information of company’s business activities. The report covers  |  read more...
$500.00
Digna Biotech, S.L. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Digna Biotech, S.L. (Digna) is a biotechnology company. The company generates robust clinical therapeutic and diagnostic candidates. It has eighteen products including 12 therapeutic candidates, four clinical-Stage Products, panning 23 indications across six key franchises,  |  read more...
$750.00
Daiichi Sankyo Company, Limited – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Daiichi Sankyo Company, Limited – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Daiichi Sankyo Company, Limited - Product Pipeline Review - 2013” provides data on the Daiichi Sankyo Company, Limited’s research and development  |  read more...
$1,500.00
Daewoong Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Daewoong Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013” provides data on the Daewoong Pharmaceutical Co., Ltd.’s research and development  |  read more...
$1,500.00
Danone, Groupe in Packaged Food (World)
4/18/2013 | published by: Euromonitor International
Danone, Groupe in Packaged Food (World) Danone’s key interests in packaged food are dairy and baby food. The company’s dairy presence however remains overly reliant on the mature Western European market. Baby food growth for the  |  read more...
$520.00
Danone , Groupe in Soft Drinks (World)
4/18/2013 | published by: Euromonitor International
Danone , Groupe in Soft Drinks (World) Danone is the global leader in bottled water. Danone has been successful at developing local and regional brands in emerging markets to support growth. In 2012, Bonafont, based almost  |  read more...
$520.00